Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial
<p>Abstract</p> <p>Background</p> <p>Ultrasound contrast agents (UCAs) allow the enhancement of vascular definition, thereby providing more diagnostic information. LK565 is a new second-generation UCA based on synthetic polymers of aspartic acid which is eliminated from the blood stream via phagocyt...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2004-09-01
|
| Цуврал: | Cardiovascular Ultrasound |
| Онлайн хандалт: | http://www.cardiovascularultrasound.com/content/2/1/16 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|